Sortilin

Sortilin 분자 정보

영어 이름Sortilin시판 약물 수0
임상 약물 수3표적 별명100 kDa NT receptor,NT3,Glycoprotein 95,LDLCQ6,NTR3,Gp95,Sortilin 1,Neurotensin receptor 3
최고 연구 개발 단계Phase 2 Clinical
영어 이름Sortilin
표적 별명100 kDa NT receptor,NT3,Glycoprotein 95,LDLCQ6,NTR3,Gp95,Sortilin 1,Neurotensin receptor 3
시판 약물 수0
임상 약물 수3
최고 연구 개발 단계Phase 2 Clinical

Sortilin 제품 목록

  • 속성

    Protein (5)Cell (1)

  • 제품 라이브러리

    온라인 (6)

  • Human (3)Cynomolgus (1)Rat (1)Canine (1)

  • 태그

    His Tag (4)His Tag & Avi Tag (1)- (1)

  • 마커

    Unconjugated (4)Biotin-labeled (1)- (1)

Sortilin분자 배경

The Sortilin is a sorting receptor in the Golgi compartment and as a clearance receptor on the cell surface. Required for protein transport from the Golgi apparatus to the lysosomes by a pathway that is independent of the mannose-6-phosphate receptor (M6PR). Lysosomal proteins bind specifically to the receptor in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelysosomal compartment where the low pH mediates the dissociation of the complex. The receptor is then recycled back to the Golgi for another round of trafficking through its binding to the retromer.

Sortilin분자 별명

Sortilin,SORT1,100 kDa NT receptor,Glycoprotein 95,Gp95,Gp95LDLCQ6,Neurotensin receptor 3,NT3NTR3,Ntr3,sortilin 1,

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
VES-001VES001; VES-001Phase 2 ClinicalVesper Bio APSDementia; Frontotemporal Dementia; Frontotemporal Lobar Degeneration
상세
LatozinemabAL-001; GSK-4527223Phase 1 ClinicalAlector Inc, Glaxosmithkline PlcAmyotrophic Lateral Sclerosis; Frontotemporal Dementia; Neurodegenerative Diseases
상세
ARB-1-6ARB-1-6; PQ-203Phase 1 ClinicalProteinQure IncBreast Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호